Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites
NCT ID: NCT00352729
Last Updated: 2015-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2006-11-30
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: The mean healing time for wounds treated with the ACell dressing will be less than the mean healing time for wounds treated with the Standard of Care dressing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
NCT02380612
Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds
NCT01268189
Continued Access to the Recell® Device for Treatment of Acute Burn Injuries
NCT03333941
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
NCT00581217
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
NCT02994654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
ACell dressing
dressing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACell dressing
dressing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* burn wounds do not involve the donor site harvesting areas
* requires excision and grafting of sufficient extent to justify two donor site of roughly equal size on non-dependent body surfaces.
* The scheduled excision and grafting procedure is the first such operation for the subject
* subject agrees to participate in follow-up evaluations
Exclusion Criteria
* Major acute or chronic medical illness that could affect wound healing
* Cellulitis or other infection of the potential donor sites
* Donor site has been previously harvested for grafting
* Subjects who are pregnant
* Religious objections or allergy to porcine products
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Army Institute of Surgical Research
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
USAISR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Albrecht, MD
Role: PRINCIPAL_INVESTIGATOR
U.S. Army Institute of Surgical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
U.S. Army Insitute of Surgical Research
Fort Sam Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol. 2004 Apr;12(3-4):367-77. doi: 10.1016/j.trim.2003.12.016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-06-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.